This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fassnacht, M. Articles by Allolio, B. Search for Related Content PubMed PubMed Citation Articles by Fassnacht, M. Articles by Allolio, B.

N-Terminal Proopiomelanocortin Acts as a Mitogen in Adrenocortical Tumor Cells and Decreases Adrenal Steroidogenesis

Department of Medicine, Endocrine and Diabetes Unit (M.F., S.H., I.A.H., T.K., M.Z., B.A.), Department of Orthopedics (F.J.), and Institut fuer Medizinische Strahlenkunde und Zellforschung (J.T.), University of Wurzburg, Wurzburg 97080, Germany; and IPF PharmaCeuticals GmbH (K.A.), 30625 Hannover, Germany

Address all correspondence and requests for reprints to: Martin Fassnacht, M.D., Department of Medicine, Endocrine and Diabetes Unit, University of Wurzburg, 97080 Wurzburg, Germany. E-mail: Fassnacht-M{at}medizin.uni-wuerzburg.de.

There is evidence that proopiomelanocortin (POMC)-derived peptides other than ACTH are involved in pituitary-dependent adrenal growth. We have synthesized the human N-terminal POMC fragment 1-28-POMC with the disulfide bridges in the correct position between cysteine residues 2–24 and 8–20 and studied the activity of these peptides in adrenocortical tumor cells in vitro. 1-28-POMC stimulated cell proliferation in human NCI-h295 and mouse Y-1 adrenal cancer cell lines and also in primary cultures of bovine adrenocortical cells in a concentration-dependent manner. 1-28-POMC led to rapid activation of the MAPKs extracellular signal-regulated kinases-1 and -2, but not c-Jun N-terminal kinase and p38, pathways. Steroid hormone production (cortisol, 17-hydroxyprogesterone, and dehydroepiandrosterone sulfate) in NCI-h295 cells was decreased by 1-28-POMC in a concentration-dependent fashion. However, protein levels of important regulators of steroidogenesis [steroidogenic factor-1, DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome 1), steroidogenic acute regulatory protein, and cytochrome P450 side-chain cleavage enzyme] remained unaffected by 1-28-POMC treatment. Our results provide evidence that synthetic 1-28-POMC induces adrenal tumor cell proliferation, inhibits adrenal steroidogenesis, and mediates its action by signaling via the extracellular signal-regulated kinase pathway. The distinct roles of 1-28-POMC and ACTH in the regulation of adrenal growth and steroidogenesis suggest that the adrenal cortex is under the dual opposing control of fragments from the same mother peptide POMC.

This work was supported by the Deutsche Forschungsgemeinschaft (Grant Al 203/7-1, to B.A.).

Present address for J.T.: Daniel-Swarovski Research Lab, Department of Surgery, University of Innsbruck, 6020 Innsbruck, Austria.

Abbreviations: AsP, Adrenal secretory protease; bFGF, basic fibroblast growth factor; DAX-1, dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome 1; DHEA-S, dehydroepiandrosterone sulfate; ESIMS, electrospray ionization mass spectrometry; FCS, fetal calf serum; IgG, immunoglobulin G; JNK, c-Jun N-terminal kinase; MEK, MAPK kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide; N-POMC, N-terminal proopiomelanocortin; 17-OH-P, 17-hydroxyprogesterone; P40scc, cytochrome P450 side-chain cleavage enzyme; POMC, proopiomelanocortin; SF-1, steroidogenic factor 1; StAR, steroidogenic acute regulatory protein.

This article has been cited by other articles:

				M. Doghman, T. Karpova, G. A. Rodrigues, M. Arhatte, J. De Moura, L. R. Cavalli, V. Virolle, P. Barbry, G. P. Zambetti, B. C. Figueiredo, et al. Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and Cancer Mol. Endocrinol., December 1, 2007; 21(12): 2968 - 2987. [Abstract] [Full Text] [PDF]

				J. G Ferreira, C. D Cruz, D. Neves, and D. Pignatelli Increased extracellular signal regulated kinases phosphorylation in the adrenal gland in response to chronic ACTH treatment J. Endocrinol., March 1, 2007; 192(3): 647 - 658. [Abstract] [Full Text] [PDF]

				T. T. To, S. Hahner, G. Nica, K. B. Rohr, M. Hammerschmidt, C. Winkler, and B. Allolio Pituitary-Interrenal Interaction in Zebrafish Interrenal Organ Development Mol. Endocrinol., February 1, 2007; 21(2): 472 - 485. [Abstract] [Full Text] [PDF]

				J. L. Smart, V. Tolle, V. Otero-Corchon, and M. J. Low Central Dysregulation of the Hypothalamic-Pituitary-Adrenal Axis in Neuron-Specific Proopiomelanocortin-Deficient Mice Endocrinology, February 1, 2007; 148(2): 647 - 659. [Abstract] [Full Text] [PDF]

				A. P Coll, M. Fassnacht, S. Klammer, S. Hahner, D. M Schulte, S. Piper, Y C L. Tung, B. G Challis, Y. Weinstein, B. Allolio, et al. Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. J. Endocrinol., August 1, 2006; 190(2): 515 - 525. [Abstract] [Full Text] [PDF]

				A. Robinson-White, E. Meoli, S. Stergiopoulos, A. Horvath, S. Boikos, I. Bossis, and C. A. Stratakis PRKAR1AMutations and Protein Kinase A Interactions with Other Signaling Pathways in the Adrenal Cortex J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2380 - 2388. [Abstract] [Full Text] [PDF]

				O. Zwermann, D. M Schulte, M. Reincke, and F. Beuschlein ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo Eur. J. Endocrinol., September 1, 2005; 153(3): 435 - 444. [Abstract] [Full Text] [PDF]

				M. Fassnacht, D. Weismann, S. Ebert, P. Adam, M. Zink, F. Beuschlein, S. Hahner, and B. Allolio AKT Is Highly Phosphorylated in Pheochromocytomas But Not in Benign Adrenocortical Tumors J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4366 - 4370. [Abstract] [Full Text] [PDF]

				J. Karpac, D. Ostwald, S. Bui, P. Hunnewell, M. Shankar, and U. Hochgeschwender Development, Maintenance, and Function of the Adrenal Gland in Early Postnatal Proopiomelanocortin-Null Mutant Mice Endocrinology, June 1, 2005; 146(6): 2555 - 2562. [Abstract] [Full Text] [PDF]

				S. Hahner, M. Fassnacht, F. Hammer, M. Schammann, D. Weismann, I. A. Hansen, and B. Allolio Evidence against a role of human airway trypsin-like protease - the human analogue of the growth-promoting rat adrenal secretory protease - in adrenal tumourigenesis Eur. J. Endocrinol., January 1, 2005; 152(1): 143 - 153. [Abstract] [Full Text] [PDF]

				A. P. Coll, B. G. Challis, G. S. H. Yeo, K. Snell, S. J. Piper, D. Halsall, R. R. Thresher, and S. O'Rahilly The Effects of Proopiomelanocortin Deficiency on Murine Adrenal Development and Responsiveness to Adrenocorticotropin Endocrinology, October 1, 2004; 145(10): 4721 - 4727. [Abstract] [Full Text] [PDF]

				I. A. Hansen, M. Fassnacht, S. Hahner, F. Hammer, M. Schammann, S. R. Meyer, A. B. Bicknell, and B. Allolio The Adrenal Secretory Serine Protease AsP Is a Short Secretory Isoform of the Transmembrane Airway Trypsin-Like Protease Endocrinology, April 1, 2004; 145(4): 1898 - 1905. [Abstract] [Full Text] [PDF]